Baseline Cardiovascular Risk Assessment In Cancer Patients With Cancer

This session focuses on the importance of baseline cardiovascular risk assessment in cancer patients prior to initiating potentially cardiotoxic therapies. Participants will learn to identify high-risk individuals using clinical evaluation, diagnostic tools (ECG, echocardiogram, biomarkers), and validated models like HFA-ICOS. The program emphasizes early detection, risk stratification, and interdisciplinary management to optimize cancer treatment outcomes and reduce cardiovascular... Read more